Cencora (NYSE:COR) Director Lauren Tyler Buys 550 Shares

Cencora, Inc. (NYSE:COR) Director Lauren Tyler acquired 550 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the transaction, the director directly owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This represents a 14.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Cencora Price Performance

Shares of NYSE COR opened at $284.94 on Thursday. The firm has a market capitalization of $55.44 billion, a P/E ratio of 21.85, a PEG ratio of 1.52 and a beta of 0.59. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The company’s fifty day moving average is $282.09 and its two-hundred day moving average is $322.80. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts forecast that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has approved a share buyback plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Leerink Partners restated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Wells Fargo & Company dropped their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Robert W. Baird cut their price objective on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Evercore set a $360.00 target price on Cencora in a research note on Wednesday, April 8th. Finally, William Blair began coverage on Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating for the company. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $367.75.

Hedge Funds Weigh In On Cencora

Several institutional investors and hedge funds have recently modified their holdings of COR. Kemnay Advisory Services Inc. purchased a new stake in Cencora in the 4th quarter worth approximately $25,000. Oakworth Capital Inc. purchased a new position in shares of Cencora during the 4th quarter worth $26,000. Elyxium Wealth LLC acquired a new stake in shares of Cencora during the fourth quarter worth $27,000. Archer Investment Corp grew its position in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the period. Finally, Motiv8 Investments LLC purchased a new stake in shares of Cencora in the fourth quarter valued at $29,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.